# Affiliated Managers Group, Inc.: financial statements, quarterly

AMG · NYSE · CIK 1004434 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amg.md) · [Financials](/companies/amg/financials.md) · [Filings](/companies/amg/filings.md) · [Insiders](/companies/amg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [525](/filings/0001004434-24-000049.md) | [503 d](/filings/0001628280-26-008665.md) | [500](/filings/0001004434-25-000039.md) | [500](/filings/0001004434-25-000045.md) | [516](/filings/0001628280-25-050206.md) | [524 d](/filings/0001628280-26-008665.md) | [497](/filings/0001628280-26-032153.md) | [493](/filings/0001628280-26-054930.md) | [528](/filings/0001628280-25-050206.md) | [557 d](/filings/0001628280-26-008665.md) | [545](/filings/0001628280-26-032153.md) | [641](/filings/0001628280-26-054930.md) |
| Selling, general and administrative | $m | [91.1](/filings/0001004434-24-000049.md) | [84.8 d](/filings/0001628280-26-008665.md) | [91.7](/filings/0001004434-25-000039.md) | [89.4](/filings/0001004434-25-000045.md) | [97.0](/filings/0001628280-25-050206.md) | [98.4 d](/filings/0001628280-26-008665.md) | [94.7](/filings/0001628280-26-032153.md) | [95.7](/filings/0001628280-26-054930.md) | [101](/filings/0001628280-25-050206.md) | [118 d](/filings/0001628280-26-008665.md) | [107](/filings/0001628280-26-032153.md) | [107](/filings/0001628280-26-054930.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [31.1](/filings/0001004434-23-000034.md) | [31.4 d](/filings/0001004434-24-000010.md) | [29.9](/filings/0001004434-24-000030.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [77.7](/filings/0001004434-24-000049.md) | [29.9 d](/filings/0001628280-26-008665.md) | [55.4](/filings/0001004434-25-000039.md) | [43.3](/filings/0001004434-25-000045.md) | [31.3](/filings/0001628280-25-050206.md) | [52.6 d](/filings/0001628280-26-008665.md) | [27.4](/filings/0001628280-26-032153.md) | [35.7](/filings/0001628280-26-054930.md) | [71.6](/filings/0001628280-25-050206.md) | [148 d](/filings/0001628280-26-008665.md) | [46.5](/filings/0001628280-26-032153.md) | [70.0](/filings/0001628280-26-054930.md) |
| Net income | $m | [217](/filings/0001004434-24-000049.md) | [196 d](/filings/0001628280-26-008665.md) | [150](/filings/0001004434-25-000039.md) | [76.0](/filings/0001004434-25-000045.md) | [124](/filings/0001628280-25-050206.md) | [162 d](/filings/0001628280-26-008665.md) | [72.4](/filings/0001628280-26-032153.md) | [84.3](/filings/0001628280-26-054930.md) | [212](/filings/0001628280-25-050206.md) | [348 d](/filings/0001628280-26-008665.md) | [110](/filings/0001628280-26-032153.md) | [186](/filings/0001628280-26-054930.md) |
| Diluted EPS | $ per share | [5.48](/filings/0001004434-24-000049.md) | not reported | [4.14](/filings/0001004434-25-000039.md) | [2.26](/filings/0001004434-25-000045.md) | [3.78](/filings/0001628280-25-050206.md) | not reported | [2.20](/filings/0001628280-26-032153.md) | [2.80](/filings/0001628280-26-054930.md) | [6.87](/filings/0001628280-25-050206.md) | not reported | [3.84](/filings/0001628280-26-032153.md) | [6.95](/filings/0001628280-26-054930.md) |
| Basic EPS | $ per share | [6.22](/filings/0001004434-24-000049.md) | not reported | [4.56](/filings/0001004434-25-000039.md) | [2.42](/filings/0001004434-25-000045.md) | [4.11](/filings/0001628280-25-050206.md) | not reported | [2.48](/filings/0001628280-26-032153.md) | [2.96](/filings/0001628280-26-054930.md) | [7.47](/filings/0001628280-25-050206.md) | not reported | [4.12](/filings/0001628280-26-032153.md) | [7.05](/filings/0001628280-26-054930.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [999](/filings/0001004434-23-000034.md) | [814](/filings/0001004434-25-000010.md) | [793](/filings/0001004434-24-000030.md) | [866](/filings/0001004434-24-000040.md) | [1,011](/filings/0001004434-24-000049.md) | [950](/filings/0001628280-26-008665.md) | [817](/filings/0001004434-25-000039.md) | [361](/filings/0001004434-25-000045.md) | [476](/filings/0001628280-25-050206.md) | [586](/filings/0001628280-26-054930.md) | [376](/filings/0001628280-26-032153.md) | [411](/filings/0001628280-26-054930.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [9,004](/filings/0001004434-23-000034.md) | [9,060](/filings/0001004434-25-000010.md) | [9,025](/filings/0001004434-24-000030.md) | [8,845](/filings/0001004434-24-000040.md) | [8,903](/filings/0001004434-24-000049.md) | [8,831](/filings/0001628280-26-008665.md) | [8,714](/filings/0001004434-25-000039.md) | [8,808](/filings/0001004434-25-000045.md) | [8,928](/filings/0001628280-25-050206.md) | [9,207](/filings/0001628280-26-054930.md) | [9,396](/filings/0001628280-26-032153.md) | [9,404](/filings/0001628280-26-054930.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [4,107](/filings/0001004434-23-000034.md) | [4,096](/filings/0001004434-25-000010.md) | [4,111](/filings/0001004434-24-000030.md) | [4,191](/filings/0001004434-24-000040.md) | [4,232](/filings/0001004434-24-000049.md) | [4,182](/filings/0001628280-26-008665.md) | [4,249](/filings/0001004434-25-000039.md) | [4,333](/filings/0001004434-25-000045.md) | [4,388](/filings/0001628280-25-050206.md) | [4,785](/filings/0001628280-26-054930.md) | [5,148](/filings/0001628280-26-032153.md) | [5,200](/filings/0001628280-26-054930.md) |
| Long-term debt | $m | [2,537](/filings/0001004434-23-000034.md) | [2,538](/filings/0001004434-25-000010.md) | [2,525](/filings/0001004434-24-000030.md) | [2,525](/filings/0001004434-24-000040.md) | [2,620](/filings/0001004434-24-000049.md) | [2,620](/filings/0001628280-26-008665.md) | [2,621](/filings/0001004434-25-000039.md) | [2,621](/filings/0001004434-25-000045.md) | [2,372](/filings/0001628280-25-050206.md) | [2,691](/filings/0001628280-26-054930.md) | [2,919](/filings/0001628280-26-032153.md) | [3,004](/filings/0001628280-26-054930.md) |
| Shareholders' equity | $m | [3,495](/filings/0001004434-23-000034.md) | [3,588](/filings/0001004434-25-000010.md) | [3,590](/filings/0001004434-24-000030.md) | [3,331](/filings/0001004434-24-000040.md) | [3,316](/filings/0001004434-24-000049.md) | [3,345](/filings/0001628280-26-008665.md) | [3,188](/filings/0001004434-25-000039.md) | [3,239](/filings/0001004434-25-000045.md) | [3,343](/filings/0001628280-25-050206.md) | [3,238](/filings/0001628280-26-054930.md) | [3,090](/filings/0001628280-26-032153.md) | [3,038](/filings/0001628280-26-054930.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [294 d](/filings/0001004434-24-000049.md) | [255 d](/filings/0001628280-26-008665.md) | [209](/filings/0001004434-25-000039.md) | [245 d](/filings/0001004434-25-000045.md) | [265 d](/filings/0001628280-25-050206.md) | [213 d](/filings/0001628280-26-008665.md) | [209](/filings/0001628280-26-032153.md) | [231 d](/filings/0001628280-26-054930.md) | [277 d](/filings/0001628280-25-050206.md) | [256 d](/filings/0001628280-26-008665.md) | [299](/filings/0001628280-26-032153.md) | [239 d](/filings/0001628280-26-054930.md) |
| Capital expenditure | $m | [2.6 d](/filings/0001004434-24-000049.md) | [5.8 d](/filings/0001628280-26-008665.md) | [1.0](/filings/0001004434-25-000039.md) | [0.6 d](/filings/0001004434-25-000045.md) | [0.7 d](/filings/0001628280-25-050206.md) | [1.1 d](/filings/0001628280-26-008665.md) | [1.6](/filings/0001628280-26-032153.md) | [1.4 d](/filings/0001628280-26-054930.md) | [1.2 d](/filings/0001628280-25-050206.md) | [1.9 d](/filings/0001628280-26-008665.md) | [3.8](/filings/0001628280-26-032153.md) | [0.0 d](/filings/0001628280-26-054930.md) |
| Dividends paid | $m | [0.4 d](/filings/0001004434-24-000049.md) | [0.3 d](/filings/0001628280-26-008665.md) | [0.3](/filings/0001004434-25-000039.md) | [0.4 d](/filings/0001004434-25-000045.md) | [0.3 d](/filings/0001628280-25-050206.md) | [0.4 d](/filings/0001628280-26-008665.md) | [0.3](/filings/0001004434-25-000039.md) | [0.2 d](/filings/0001004434-25-000045.md) | [0.3 d](/filings/0001628280-25-050206.md) | [0.2 d](/filings/0001628280-26-008665.md) | not reported | not reported |
| Share repurchases | $m | [169 d](/filings/0001004434-24-000049.md) | [128 d](/filings/0001628280-26-008665.md) | [153](/filings/0001004434-25-000039.md) | [332 d](/filings/0001004434-25-000045.md) | [105 d](/filings/0001628280-25-050206.md) | [120 d](/filings/0001628280-26-008665.md) | [176](/filings/0001628280-26-032153.md) | [101 d](/filings/0001628280-26-054930.md) | [75.7 d](/filings/0001628280-25-050206.md) | [353 d](/filings/0001628280-26-008665.md) | [185](/filings/0001628280-26-032153.md) | [180 d](/filings/0001628280-26-054930.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.5](/filings/0001004434-23-000034.md) | [39.9](/filings/0001004434-24-000030.md) | [42.1](/filings/0001004434-24-000040.md) | [43.4](/filings/0001004434-24-000049.md) | [40.1](/filings/0001004434-25-000039.md) | [35.3](/filings/0001004434-25-000045.md) | [35.0](/filings/0001628280-25-050206.md) | [32.6](/filings/0001628280-26-032153.md) | [31.4](/filings/0001628280-26-054930.md) | [32.9](/filings/0001628280-25-050206.md) | [27.5](/filings/0001628280-26-032153.md) | [26.9](/filings/0001628280-26-054930.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,859,933 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054930.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.